CCIA
AVNS

Campbell & Co Investment Adviser’s Avanos Medical AVNS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,536
Closed -$466K – 1137
2025
Q1 		$466K Sell
32,536
-40,500
-55% -$632K 0.04% 705
2024
Q4 		$1.16M Buy
+73,036
New +$1.45M 0.09% 341
2024
Q3 		– Sell
-18,004
Closed -$359K – 1085
2024
Q2 		$359K Sell
18,004
-5,457
-23% -$106K 0.03% 770
2024
Q1 		$467K Sell
23,461
-22,908
-49% -$443K 0.04% 728
2023
Q4 		$1.04M Buy
+46,369
New +$957K 0.09% 376
2023
Q2 		– Sell
-8,502
Closed -$253K – 873
2023
Q1 		$253K Buy
+8,502
New +$247K 0.05% 664
2022
Q2 		– Sell
-14,200
Closed -$476K – 680
2022
Q1 		$476K Buy
+14,200
New +$457K 0.13% 295
2021
Q4 		– Sell
-22,100
Closed -$690K – 618
2021
Q3 		$690K Sell
22,100
-5,100
-19% -$173K 0.22% 133
2021
Q2 		$989K Buy
+27,200
New +$1.12M 0.41% 45
2019
Q3 		– Sell
-7,353
Closed -$321K – 601
2019
Q2 		$321K Buy
+7,353
New +$315K 0.15% 289

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Campbell & Co Investment Adviser's AVNS Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 32,536 shares — an estimated $466K sold.

Campbell & Co Investment Adviser first reported a position in AVNS in Q2 2019 and held it in 10 quarters. The position peaked at $1.16M in Q4 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Campbell & Co Investment Adviser reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 32,536 Avanos Medical shares in Q2 2025, an estimated $466K.
  • Campbell & Co Investment Adviser first reported a position in Avanos Medical in Q2 2019 and held it in 10 quarters.
  • Campbell & Co Investment Adviser's Avanos Medical position peaked at $1.16M in Q4 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.